Front Row Advisors’s Molina Healthcare MOH Stock Holding History

Front Row Advisors’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-17	Closed	-$5.57K	–	678
2023 Q3	$5.57K	Sell	17 -1	-6%	-$315	﹤0.01%	644
2023 Q2	$5K	Hold	18	–	–	﹤0.01%	673
2023 Q1	$5K	Hold	18	–	–	﹤0.01%	679
2022 Q4	$6K	Sell	18 -2	-10%	-$679	﹤0.01%	617
2022 Q3	$7K	Hold	20	–	–	﹤0.01%	577
2022 Q2	$6K	Buy	20 +2	+11%	+$604	﹤0.01%	631
2022 Q1	$6K	Sell	18 -4	-18%	-$1.23K	﹤0.01%	674
2021 Q4	$7K	Sell	22 -2	-8%	-$595	﹤0.01%	671
2021 Q3	$7K	Hold	24	–	–	﹤0.01%	660
2021 Q2	$6K	Hold	24	–	–	﹤0.01%	700
2021 Q1	$6K	Hold	24	–	–	﹤0.01%	688
2020 Q4	$5K	Hold	24	–	–	﹤0.01%	692
2020 Q3	$5K	Sell	24 -11	-31%	-$2K	﹤0.01%	691
2020 Q2	$6K	Hold	35	–	–	﹤0.01%	596
2020 Q1	$6K	Buy	+35	New	+$4.68K	﹤0.01%	585

Other funds holding MOH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Front Row Advisors's MOH Position: Q4 2023 in Review

Front Row Advisors sold out of Molina Healthcare (MOH) in Q4 2023, closing a stake of 17 shares — an estimated $5.57K sold.

Front Row Advisors first reported a position in MOH in Q1 2020 and held it in 15 quarters. The position peaked at $7K in Q3 2022. 609 funds tracked by Wall St. Rank hold MOH as of Q4 2023.

Front Row Advisors reported no remaining Molina Healthcare position as of Q4 2023 after selling out during the quarter.
Front Row Advisors sold 17 Molina Healthcare shares in Q4 2023, an estimated $5.57K.
Front Row Advisors first reported a position in Molina Healthcare in Q1 2020 and held it in 15 quarters.
Front Row Advisors's Molina Healthcare position peaked at $7K in Q3 2022.
609 funds tracked by Wall St. Rank held Molina Healthcare as of Q4 2023.

Based on Front Row Advisors's 13F filing for Q4 2023, filed 15 Feb 2024.